KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVS) Gross Profit (2016 - 2025)

Historic Gross Profit for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $10.2 billion.

  • Novartis Ag's Gross Profit rose 14.66% to $10.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $43.0 billion, marking a year-over-year increase of 1048.98%. This contributed to the annual value of $43.0 billion for FY2025, which is 1048.98% up from last year.
  • Latest data reveals that Novartis Ag reported Gross Profit of $10.2 billion as of Q4 2025, which was up 14.66% from $10.8 billion recorded in Q3 2025.
  • Over the past 5 years, Novartis Ag's Gross Profit peaked at $11.5 billion during Q2 2025, and registered a low of $7.9 billion during Q3 2022.
  • In the last 5 years, Novartis Ag's Gross Profit had a median value of $9.4 billion in 2021 and averaged $9.4 billion.
  • As far as peak fluctuations go, Novartis Ag's Gross Profit crashed by 1698.09% in 2022, and later soared by 1871.33% in 2025.
  • Quarter analysis of 5 years shows Novartis Ag's Gross Profit stood at $9.5 billion in 2021, then fell by 16.98% to $7.9 billion in 2022, then grew by 10.46% to $8.8 billion in 2023, then grew by 16.91% to $10.2 billion in 2024, then grew by 0.15% to $10.2 billion in 2025.
  • Its Gross Profit stands at $10.2 billion for Q4 2025, versus $10.8 billion for Q3 2025 and $11.5 billion for Q2 2025.